OmniAb, Inc.·4

Feb 18, 6:34 PM ET

FOEHR MATTHEW W 4

Research Summary

AI-generated summary

Updated

OmniAb (OABI) CEO Matthew W. Foehr Receives RSUs, Sells Shares

What Happened

  • Matthew W. Foehr, President, CEO and Director of OmniAb (OABI), had derivative awards convert and RSUs granted/vested on Feb 18, 2026 and sold 30,843 shares in an open‑market "sell-to-cover" for $52,742 (weighted avg $1.71).
  • The filing shows conversion/exercise or similar derivative activity of 58,333 shares, two award/grant entries for 156,250 and 1,562,500 RSU-type units (all recorded at $0.00 as derivative awards), for a total of 1,777,083 shares acquired/awarded on that date. Separately, 58,333 derivative shares are also listed as disposed at $0.00 in the filing.

Key Details

  • Transaction date: 2026-02-18 (filed same day).
  • Sale: 30,843 shares sold at a weighted average price of $1.71; total proceeds reported $52,742. Reported per‑share prices in the sale ranged $1.68–$1.73.
  • Awards/Conversions: 58,333 shares (exercise/conversion), 156,250 RSUs (award), and 1,562,500 RSUs (award) recorded as acquired (all reported at $0.00 as derivative/award entries).
  • Derivative disposition: 58,333 shares listed as disposed at $0.00 (reported as derivative).
  • Shares owned after the transaction: not disclosed in the provided filing summary.
  • Footnotes of note:
    • F1/F5: RSU grants vest in substantially equal annual installments (one set beginning Feb 18, 2026; another beginning Feb 18, 2027).
    • F2: Each RSU represents the contingent right to one share of common stock.
    • F3/F4: The open‑market sale was a mandatory sell‑to‑cover to satisfy tax withholding; sale price shown is a weighted average (range $1.68–$1.73).
    • F6: Stock option grant vesting schedule noted (12.5% after 6 months, then monthly thereafter).
  • Filing timeliness: No late filing was indicated (filed same day as reported transactions).

Context

  • This activity appears primarily related to awards/derivative conversion and compulsory tax‑covering sales, not discretionary open‑market selling: the filing documents mandatory sell‑to‑cover to satisfy withholding obligations (per footnote).
  • For derivative items: a conversion/exercise entry and zero‑proceeds derivative disposition are shown; those entries are recorded as derivative transactions in the Form 4 and may reflect internal settling/withholding mechanics rather than voluntary cash sales.